UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007536
Receipt number R000008903
Scientific Title Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing and treating diabetic macular edema
Date of disclosure of the study information 2012/03/20
Last modified on 2019/03/26 12:10:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing and treating diabetic macular edema

Acronym

Use of nonmydriatic OCT for diagnosing and treating diabetic macular edema

Scientific Title

Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing and treating diabetic macular edema

Scientific Title:Acronym

Use of nonmydriatic OCT for diagnosing and treating diabetic macular edema

Region

Japan


Condition

Condition

diabetic retinopathy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the accuracy of spectral-domain optical coherence tomography (OCT)devices before and after mydriasis for the diagnosis and treatment of diabetic retinopathy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

visual acuity,intraocular pressure,macular thickness and retinal nerve fiber thickness
(before and after mydriasis)

Key secondary outcomes

subjective symptom


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

mensuration of central retinal thickness and reinal nerve fiber thickness by SD OCT instruments before and after pupil dilation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Male or female patients with diabetis mellitus type 1 or 2 who meet the WHO or ADA creteria for diabetes
Without medical examination within 1 year
Adequate pupil dilatation and clear media to perform digital photography and OCT scans

Key exclusion criteria

Recent (last 6 months) or ongoing poor glycaemic control (HbA1c greater than 10.0mg/dl)
Uncontrolled hypertension (BP greater than 180/110mmHg)
Any previous surgical or laser treatment to the study eye

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takao
Middle name
Last name Hirano

Organization

Shinshu university school of midecine

Division name

department of ophthalmology

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Nagano, Japanagano

TEL

+81-263-37-2664

Email

takaoh@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Takao
Middle name
Last name Hirano

Organization

Shinshu university school of medicine

Division name

department of ophthalmology

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Nagano, Japanagano

TEL

+81-263-37-2664

Homepage URL


Email

takaoh@shinshu-u.ac.jp


Sponsor or person

Institute

Takao Hirano

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Review Board of Clinical Research

Address

3-1-1 Asahi, Matsumoto, Nagano, 390-8621 Japan

Tel

0263-37-2576ext.5153

Email

ieganka@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

信州大学附属病院(長野県)


Other administrative information

Date of disclosure of the study information

2012 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2012 Year 03 Month 20 Day

Date of IRB


Anticipated trial start date

2012 Year 03 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 03 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 03 Month 20 Day

Last modified on

2019 Year 03 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008903


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name